Patent · US Active

Chimeric yellow fever ZIKA virus strain

US11351240B2 · kind B2 · utility

0Cited by

0References

20Claims

0Family size

Assignee

Katholieke Universiteit Leuven · BE

Inventors

Kai Dallmeier · Kessel-Lo, BE
Dieudonné Buh Kum · Aarschot, BE
Niraj Kumar Mishra · Bengaluru, IN
Johan Neyts · Namur, BE
Michael Alexander Schmid · Lumino, CH

Key dates

Filing date	Oct 5, 2018
Grant date	Jun 7, 2022
Priority date	—
Expiry date	Oct 5, 2038

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to chimeric yellow fever—Zika strains and attenuated versions thereof, wherein the nucleotide sequence encoding the signal sequence and prME protein of said yellow virus is replaced by a nucleotide sequence encoding the signal sequence and the prME protein of a Zika virus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.